IL-6 was initially thought to play a major role in immune and inflammatory responses, however IL6 abnormalities were found in many types of cancer, and some evidence showed that in cancer IL6 may play its downstream effects through JAK/STAT pathway [33–35]. This evidence concerns the gene IL6 and cancer.